Revenue Estimates Analysis of Antero Midstream GP LP(NYSE:AMGP): Bausch Health Companies Inc.(NYSE:BHC)

0
2

The Relative Volume of the company is 0 and Average Volume (3 months) is 0 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Antero Midstream GP LP currently shows a Weekly Performance of 0%, where Monthly Performance is 0%, Quarterly performance is 0%, 6 Months performance is 0% and yearly performance percentage is 0%. Year to Date performance value (YTD perf) value is 0%. The Stock currently has a Weekly Volatility of – and Monthly Volatility of -.

Bausch Health Companies Inc. (BHC) will report its next earnings on Aug 05 BMO. The company reported the earnings of $1.02/Share in the last quarter where the estimated EPS by analysts was $0.86/share. The difference between the expected and actual EPS was $0.16/share, which represents an Earnings surprise of 18.6%.

Many analysts are providing their Estimated Earnings analysis for Bausch Health Companies Inc. and for the current quarter 14 analysts have projected that the stock could give an Average Earnings estimate of $1.04/share. These analysts have also projected a Low Estimate of $0.9/share and a High Estimate of $1.34/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for Bausch Health Companies Inc. as 2.15 Billion. According to these analysts, the Low Revenue Estimate for Bausch Health Companies Inc. is 2.08 Billion and the High Revenue Estimate is 2.22 Billion. The company had Year Ago Sales of 2.13 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for BHC to be 14%. They are projecting Next Quarter growth of -5.22%. For the next 5 years, Bausch Health Companies Inc. is expecting Growth of 2.74% per annum, whereas in the past 5 years the growth was 4.23% per annum.

Some buy side analysts are also providing their Analysis on Bausch Health Companies Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 3 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Bausch Health Companies Inc. might touch $58 high while the Average Price Target and Low price Target is $30.73 and $9 respectively.

Bausch Health Companies Inc. closed its last trading session at $24.99 with the loss of -0.28%. The Market Capitalization of the company stands at 8.75 Billion. The Company has 52-week high of $28.45 and 52-week low of $17.20. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.53% where SMA50 and SMA200 are 5.45% and 4.32% respectively. The Company Touched its 52-Week High on 10/03/18 and 52-Week Low on 12/26/18.

The Relative Volume of the company is 0.4 and Average Volume (3 months) is 4 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 5.77.

The company shows its Return on Assets (ROA) value of -4.9%. The Return on Equity (ROE) value stands at -53.8%. While it’s Return on Investment (ROI) value is -9.2%.

While looking at the Stock’s Performance, Bausch Health Companies Inc. currently shows a Weekly Performance of -1.23%, where Monthly Performance is 14.94%, Quarterly performance is -4.7%, 6 Months performance is 9.88% and yearly performance percentage is 5.82%. Year to Date performance value (YTD perf) value is 34.92%. The Stock currently has a Weekly Volatility of 2.53% and Monthly Volatility of 3.06%.

SHARE